OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← SHN management

Full background report

Dr Damien Keys

Managing Director

Career chronology

  • Current role at evidence cutoff; start date not established in reviewed source: Sunshine Metals Limited — Managing Director. Annual Financial Report 30 June 2024 (Management/director profile; current role)

Environmental record

Historical Xanadu rehabilitation liability remains under review

Latest status reported 2026-03-09; historical workings predate current CEO role · issuer reported · high materiality

Sunshine’s 31 December 2025 interim report records a $1.555m rehabilitation provision and a $114,000 security bond for historical Xanadu workings. The company says predecessor Nugold conducted mining before Sunshine’s 2002 acquisition, that the tenements were relinquished in 2009 and explored by third parties afterward, and that Sunshine disputes the scope and is reviewing which obligations stem from the acquisition versus later third-party activity. It cites a 2022 DMIRS calculator estimate of $357,000 but says consultant costing underpins the provision. At report date the legal and responsibility reviews were ongoing; no regulator or court decision allocating final liability was located. This is a material company exposure and not evidence of personal misconduct by Keys.

Attribution: Role overlaps event; causation unproven. Keys is Managing Director during current disclosure and oversight of the company’s review; the report does not attribute the underlying historic disturbance or disputed liability to him personally.

Relevance: Material environmental and financial exposure requiring continued legal, regulatory and rehabilitation oversight; final scope and allocation remain unresolved at cutoff.

Interim Financial Report 31 December 2025 (Note 7, Provision for rehabilitation, pp. 18-19)

Suitability for the current role

Role alignment; record remains incomplete

Evidence cutoff 2026-10-09 · analyst inference · low materiality

The reviewed issuer profile confirms this current role. The short public profile supports a preliminary role-alignment observation only; independent evidence on delivered outcomes and full tenure is insufficient for a broader performance judgment.

Attribution: Responsibility not applicable. This is an analyst assessment of the documented role and experience, not a claim of responsibility for a company outcome.

Relevance: Role alignment matters to execution in the current position, but the reviewed evidence does not establish full delivery or control outcomes.

Annual Financial Report 30 June 2024 (Executive or management profile: Dr Damien Keys; current role and available career detail)

Evidence gaps

  • Full dated employment chronology, independently verified education and concurrent board interests were not established from the opened sources.

  • The grouped adverse-topic search was preliminary; person-specific regulator, court, safety, environmental, insolvency, fraud and governance checks remain incomplete.

  • The later FY2025 annual report PDF linked from the issuer site timed out when opened; latest appointment and roster continuity could not be confirmed from that document.

  • Xanadu liability scope and allocation among Sunshine, Nugold and third-party activity remained under legal and regulatory review in the latest opened report (31 December 2025); no later resolution source was identified by cutoff.